Скачать с ютуб “Introducing TSHA 102” with Chelsea Karbocus and Dr Daniel Lumsden: Talk from LEAP day в хорошем качестве

“Introducing TSHA 102” with Chelsea Karbocus and Dr Daniel Lumsden: Talk from LEAP day

TSHA-102 is an experimental gene therapy developed by Taysha Gene Therapies for Rett syndrome. Chelsea Karbocus, who you will hear from in the video, is Senior Director and Head of Patient Advocacy at Taysha Gene Therapies. Dr Daniel Lumsden is a consultant paediatric neurologist and the lead neurologist at the Rett Syndrome specialist clinic at Evelina Children's Hospital. In this video, Dr Lumsden and Chelsea Karbocus explain the TSHA-102 programme. On June 1st 2024, Reverse Rett held the Learn Advocate Educate and Prepare day in Manchester. The purpose of the day was to share the most recent research information we have, and connect Rett families with researchers. To that end, we've uploaded all talks from the day to YouTube.